USPTO serial 79294807
NUCLERA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 25, 2022
- Examiner
- CHHINA, KARANENDRA S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with NUCLERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,493*
Plus Government fees of $2,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz Venable LLPP.O. Box 34385Washington, DC 20043-9998UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for scientific purposes; chemicals for use in research; chemicals, enzymes, DNA and RNA for research use; chemicals for use in the preparation and creation of DNA and RNA; enzymes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological and biochemical reagents; gene editing enzymes | ACTIVE | — |
| 005 | Biological, chemical and biochemical reagents, namely, DNA and RNA products, proteins and gene editing enzymes for clinical or medical laboratory use; pharmaceutical and veterinary preparations, namely, nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; therapeutic DNA and RNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes | ACTIVE | — |
| 009 | Scientific research and laboratory apparatus, namely, scientific desktop instruments for gene, RNA and protein synthesis; semiconductors, semiconductor chips, microchips, bio-sensors, bio-chips; scientific research and laboratory apparatus, namely, apparatus for amplifying DNA and RNA, apparatus for manufacturing DNA and RNA, apparatus for processing DNA and RNA; apparatus for recording, transmission or reproduction of data including video, audio, images and text for scientific purposes; data processing equipment and computers; computer hardware; downloadable and recorded computer software for scientific data analysis; downloadable and recorded computer programs for scientific data analysis; data carriers containing scientific data; parts and fittings for all the aforesaid goods | ACTIVE | — |
| 010 | Medical and veterinary apparatus and instruments namely, apparatus for DNA and RNA analysis, sequencing and synthesis; apparatus for gene, RNA and protein synthesis for medical and veterinary purposes | ACTIVE | — |
| 040 | Custom manufacture of therapeutic drugs, including therapeutic DNA, RNA, genes and oligonucleotides; manufacture of synthetic DNA, RNA, genes and oligonucleotides for others | ACTIVE | — |
| 042 | Scientific and technological services, namely , scientific research, structural and functional analysis of genomes and genetic testing and in the fields of genomics, DNA and RNA sequencing, gene synthesis, RNA synthesis, protein synthesis, gene identification, gene cloning, gene expression, gene mapping, and research and design in the field of DNA research and development, gene and protein synthesis; chemical and biological analysis and research services; research into DNA and RNA for scientific purposes; research and development into the creation of DNA and RNA; research, development, scientific testing and analysis in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; scientific research in the field of molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene-editing services for scientific research purposes; DNA and RNA modelling services for scientific purposes; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; creating libraries or collections of normal and mutated genes for scientific research purposes; electronic data storage services; consultancy and advisory services relating to the aforesaid services | ACTIVE | — |
| 044 | Medical and veterinary services; healthcare services; DNA and RNA screening for medical purposes; genetic and blood testing, sequencing and measuring services for medical and health purposes; provision of information relating to the analysis of DNA and RNA for medical and health purposes; providing advice and consultancy in the field of medical and veterinary therapies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nuclera Ltd
- Other trademarks owned by Nuclera Nucleics Ltd
- Other trademarks owned by Nuclera Nucleics Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NUCLERA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 25, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 30, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 29, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 25, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 25, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 17, 2021 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Dec 16, 2021 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Dec 16, 2021 | APET | ASSIGNED TO PETITION STAFF | — |
| Dec 1, 2021 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jun 29, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jun 8, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 8, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 19, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 4, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 4, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 4, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 4, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 4, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 30, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 29, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 29, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 3, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 3, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 10, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 9, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 8, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 6, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 1, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |